CARLSMED, INC.
CARLSMED, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Assets Current | |||||||||
Cash And Cash Equivalents At Carrying Value | 73 | 86 | 115 | 33 | |||||
Restricted Cash Current | 0 | 0 | 0 | 0 | |||||
Short Term Investments | 24 | 24 | - | - | |||||
Accounts Receivable Net Current | 12 | 11 | 11 | 10 | |||||
Inventory Net | 2 | 2 | 1 | 1 | |||||
Prepaid Expense And Other Assets Current | 4 | 4 | 3 | 2 | |||||
Assets Current | 115 | 127 | 131 | 46 | |||||
Property Plant And Equipment Net | 2 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 2 | 2 | 2 | 2 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 4 | |||||
Assets | 119 | 130 | 135 | 53 | |||||
Liabilities And Stockhold… | |||||||||
Liabilities Current | |||||||||
Accounts Payable Current | 3 | 4 | 3 | 3 | |||||
Accrued Liabilities Current | 3 | 3 | 3 | 3 | |||||
Accrued Employee Benefits Current | 3 | 6 | 4 | 3 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | |||||
Liabilities Current | 10 | 14 | 11 | 9 | |||||
Long Term Debt | 15 | 15 | 15 | 15 | |||||
Operating Lease Liability Noncurrent | 1 | 1 | 2 | 2 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | |||||
Liabilities | 27 | 31 | 28 | 28 | |||||
Stockholders Equity | |||||||||
Preferred Stock Value | - | 0 | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 202 | 200 | 199 | 1 | |||||
Retained Earnings Accumulated Deficit | -110 | -101 | -92 | -84 | |||||
Stockholders Equity | 92 | 99 | 107 | -83 | |||||
Liabilities And Stockholders Equity | 119 | 130 | 135 | 53 | |||||
Series A Convertible Preferred Stock | - | 0 | 0 | 0 | |||||
Series B Convertible Preferred Stock | - | 0 | 0 | 0 | |||||
Series C Convertible Preferred Stock | - | 0 | 0 | 0 | |||||
Allowance For Doubtful Accounts Receivable Current | 2 | 2 | - | 2 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 600 | 600 | 600 | 592 | |||||
Common Stock Shares Issued | 27 | 27 | 27 | 23 | |||||
Shares Outstanding | 27 | 27 | 27 | 23 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 28.03% | 31.84% | - | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | 3.36% | -1.02% | -4.24% | 36.92% | 15.31% | 11.27% | -20.46% | -12.58% | -12.34% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
CARLSMED, INC. (CARL) — SEC Financial Statements & Analysis
CARLSMED, INC. (CARL) is a surgical & medical instruments & apparatus company, incorporated in DE. CARLSMED, INC. trades on Nasdaq as: CARL. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), CARLSMED, INC. reported a Gross Profit Margin of 75.74% (TTM), a Debt-to-Equity ratio of 0.29x, a Price-to-Sales (P/S) ratio of 3.65x (TTM), a Price-to-Book (P/B) ratio of 2.63 (TTM), at a market cap of $242.86M. Figures below are sourced from SEC EDGAR, as-filed.
- Gross Profit Margin TTM
- 75.74%
- Debt To Equity
- 0.29x
- P/S TTM
- 3.65x
- P/B TTM
- 2.63
- Market Cap
- $242.86M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CARLSMED, INC. in?
CARLSMED, INC. (CARL) operates in the Surgical & Medical Instruments & Apparatus industry.
What is CARL's market cap?
CARLSMED, INC. (CARL) has a market capitalization of $242.86M as of 2026-03-31.
What exchange does CARL trade on?
CARLSMED, INC. (CARL) trades on the Nasdaq.
Where is CARLSMED, INC. incorporated?
CARLSMED, INC. is incorporated in DE.